GLP-1 medications (glucagon-like peptide-1 receptor agonists) are prescription medicines such as semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro), and dulaglutide (Trulicity) that help control blood sugar and support weight loss
While its safety profile was consistently favorable, the largest Phase IIb trial failed to show statistical significance for weight loss, and commercial development was halted in 2007.[2] Despite this, interest in AOD-9604 has continued in the compounding pharmacy and integrative medicine space, particularly given its safety data, its lack of IGF-1 stimulation, and emerging research around joint health
Research suggests that NNMT inhibition may influence metabolic pathways related to energy expenditure, fat metabolism, and cellular vitality
Diabetes Care 37 , 780788 (2014)
It has rightfully earned a reputation as one of the most beginner-friendly ingredients
9 It is commonly seen in young adults with no specific gender predilection
